StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.42−0.06 (-12.04%)

Close on Nov 17, 2026Market cap $29.10MP/E –Yield –

Telomir Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Telomir Pharmaceuticals

Telomir Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Telomir Pharmaceuticals figures

See a number that looks wrong?